Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP263021.RAjXSjk_2tf55N-kgH4vSXY2WTpikpU5n6BjSWXvotXaA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP263021.RAjXSjk_2tf55N-kgH4vSXY2WTpikpU5n6BjSWXvotXaA130_assertion type Assertion NP263021.RAjXSjk_2tf55N-kgH4vSXY2WTpikpU5n6BjSWXvotXaA130_head.
- NP263021.RAjXSjk_2tf55N-kgH4vSXY2WTpikpU5n6BjSWXvotXaA130_assertion description "[The finding of Bcl-2 overexpression in poorly differentiated NECs, particularly small cell NEC, suggests that Bcl-2 antagonists/inhibitors may be a viable treatment option for these patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263021.RAjXSjk_2tf55N-kgH4vSXY2WTpikpU5n6BjSWXvotXaA130_provenance.
- NP263021.RAjXSjk_2tf55N-kgH4vSXY2WTpikpU5n6BjSWXvotXaA130_assertion evidence source_evidence_literature NP263021.RAjXSjk_2tf55N-kgH4vSXY2WTpikpU5n6BjSWXvotXaA130_provenance.
- NP263021.RAjXSjk_2tf55N-kgH4vSXY2WTpikpU5n6BjSWXvotXaA130_assertion SIO_000772 22251937 NP263021.RAjXSjk_2tf55N-kgH4vSXY2WTpikpU5n6BjSWXvotXaA130_provenance.
- NP263021.RAjXSjk_2tf55N-kgH4vSXY2WTpikpU5n6BjSWXvotXaA130_assertion wasDerivedFrom befree-20150227 NP263021.RAjXSjk_2tf55N-kgH4vSXY2WTpikpU5n6BjSWXvotXaA130_provenance.
- NP263021.RAjXSjk_2tf55N-kgH4vSXY2WTpikpU5n6BjSWXvotXaA130_assertion wasGeneratedBy ECO_0000203 NP263021.RAjXSjk_2tf55N-kgH4vSXY2WTpikpU5n6BjSWXvotXaA130_provenance.